Luc Truyen
Chief Tech/Sci/R&D Officer at ARGENX SE
Net worth: 644 878 $ as of 30/03/2024
Profile
Luc Truyen is currently the Chief Medical Officer at argenx SE.
Previously, he held positions as the Head of Research & Development at Johnson & Johnson Pharmaceutical Group and as the Chief Marketing Officer & Head of R&D at Janssen Alzheimer Immunotherapy.
Dr. Truyen obtained a doctorate degree from the University of Antwerp.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ARGEN-X SE
0.00% | 19/02/2024 | 1,631 ( 0.00% ) | 644 878 $ | 30/03/2024 |
Luc Truyen active positions
Companies | Position | Start |
---|---|---|
ARGENX SE | Chief Tech/Sci/R&D Officer | 31/03/2022 |
Former positions of Luc Truyen
Companies | Position | End |
---|---|---|
Johnson & Johnson Pharmaceutical Group | Chief Tech/Sci/R&D Officer | - |
Janssen Alzheimer Immunotherapy | Sales & Marketing | - |
Training of Luc Truyen
University of Antwerp | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ARGENX SE | Health Technology |
Private companies | 2 |
---|---|
Johnson & Johnson Pharmaceutical Group | |
Janssen Alzheimer Immunotherapy |
- Stock Market
- Insiders
- Luc Truyen